The expression of CTH was upregulated after knockdown of Rad18 in lung cancer cells, and Rad18 silencing resulted in reduced ubiquitination levels and prolonged protein half-life of CTH, suggesting that CTH is a substrate for the E3 ubiquitin ligase Rad18. The gene discussed is RAD18; the disease is lung carcinoma.